Loading organizations...
Mintz, also known as Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, operates as an Am Law 100 full-service law firm, providing comprehensive legal counsel across a broad spectrum of practice areas. The firm specializes in corporate law, litigation, and intellectual property, serving a diverse client base that includes innovative companies in life sciences, energy, private equity, and technology. Its approach combines deep legal expertise with a focus on accelerating business objectives for its clients.
The firm's origins trace back to Boston in 1933. While specific founding members' full names beyond those in the firm's lengthy title are not readily available from direct searches, the firm was established during a period of significant economic and legal change. The initial insight likely centered on providing robust legal support to businesses navigating complex regulatory landscapes and fostering growth, a principle that has guided its expansion over the decades.
Mintz serves a roster of dynamic clients ranging from emerging enterprises to established industry leaders, particularly those at the forefront of technological and scientific advancement. The firm's overarching vision is to partner with these organizations, offering strategic legal solutions that enable them to achieve their strategic goals and navigate the evolving challenges of their respective markets, aiming to support continued innovation and expansion.
Key people at Mintz and Co..
Mintz and Co. was founded by Sergey Gribov (CTO, Co-founder).
Mintz (full name: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.) is an AmLaw 100 law firm headquartered in Boston with over 600 attorneys across offices in the US and Toronto, specializing in private equity, venture capital, emerging companies, investment funds, and portfolio company support.[9][2][7] It acts as a business accelerator for innovative companies in life sciences, technology, healthcare, energy, and financial services, providing full-service legal advice on fund formation, financings, M&A, exits, regulatory compliance, IP protection, and more.[1][3][4] The firm's mission centers on delivering high-touch, commercially grounded counsel to private equity sponsors, VC firms, startups, and institutional investors, with a strong emphasis on cross-border transactions involving US and Canadian markets.[1][4] Mintz influences the startup ecosystem through initiatives like MintzEdge, a startup accelerator offering legal tools and investor introductions, and by representing VC-backed companies from seed to IPO.[2][3]
Founded in 1933 in Boston as a real estate and banking practice with an early niche in theaters and motion pictures, Mintz evolved into a national powerhouse by expanding into litigation, transactional work, and high-growth sectors.[2] Key growth phases included bolstering financial markets in New York, regulatory expertise in Washington, DC, and tech/biotech hubs in California (San Francisco, San Diego) and Toronto since the mid-2000s, with Boston still housing over half its associates.[2][7] The firm developed specialized practices in private equity, venture capital, and emerging companies, creating ML Strategies for lobbying and MintzEdge for startups; it now ranks among the top US firms for startups, VC financings, and fund formations.[2][3][5]
Mintz rides trends in private equity middle-market buyouts, VC financings for cybersecurity/biotech (e.g., obesity/diabetes therapies), and growth equity in profitable late-stage firms, capitalizing on post-JOBS Act crowdfunding and secondary markets.[1][3][8] Timing aligns with rising cross-border investments and regulatory shifts, where its DC lobbying arm (ML Strategies) and IP/tech prowess in coastal hubs position it to navigate energy transition, health innovation, and AI-driven tech amid economic volatility.[2][7] The firm shapes the ecosystem by accelerating startups via MintzEdge, facilitating $20M+ deals, and enabling fund managers/investors to scale platforms, fostering innovation in high-regulation sectors like life sciences and telecom.[3][5]
Mintz will likely deepen cross-border PE/VC mandates amid global fund consolidation and AI/healthtech booms, expanding growth equity and secondaries as institutional capital seeks middle-market yields.[1][4] Trends like sustainability-focused buyouts and oversubscribed biotech rounds (e.g., Syntis Bio) will propel its practice, with MintzEdge amplifying startup throughput.[3][8] Its influence may evolve toward more operating-partner roles for portfolio companies, solidifying its status as a coast-to-coast accelerator for tomorrow's innovators—echoing its 90-year evolution from Boston roots to worldwide dealmaker.[2][7]
Mintz and Co. was founded by Sergey Gribov (CTO, Co-founder).
